Page last updated: 2024-11-01

niflumic acid and Astrocytoma

niflumic acid has been researched along with Astrocytoma in 1 studies

Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.

Astrocytoma: Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belsey, MJ1
Davies, AR1
Witchel, HJ1
Kozlowski, RZ1

Other Studies

1 other study available for niflumic acid and Astrocytoma

ArticleYear
Inhibition of ERK and JNK decreases both osmosensitive taurine release and cell proliferation in glioma cells.
    Neurochemical research, 2007, Volume: 32, Issue:11

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Anthracenes; Apoptosis; Astrocytoma; Cell

2007